Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."
The Precision Peptide Genetic Test ($99 after your first treatment month) analyzes key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 across 14 metabolic pathways and 150+ insights
doi: 10.1152/ajpendo.00017.2014 226 SuhSKimKW
Women should mention if they are pregnant, breastfeeding, or planning to become pregnant
Recent clinical trials reveal that despite semaglutide-induced significant weight reduction, this therapeutic effect has not corresponded to a decreased cancer risk [123]
Ethics declarations Competing interests M.D.G